Kangmei Pharma traded at 1.37 this Wednesday July 15th, increasing 0.05 or 3.79 percent since the previous trading session. Looking back, over the last four weeks, Kangmei Pharma gained 0.74 percent. Over the last 12 months, its price fell by 33.82 percent. Looking ahead, we forecast Kangmei Pharma to be priced at 1.25 by the end of this quarter and at 1.17 in one year, according to Trading Economics global macro models projections and analysts expectations.
Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others. The Company is also engaged in the trading of Chinese herbal medicines, medical equipment and healthcare products related businesses. It also engages in the provision of real estate leasing and distribution services, among others. The Company mainly conducts its businesses within domestic markets.